Simone U Dalm (S U Dalm)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Benign Prostatic Hyperplasia

Prostate Cancer

Top Venues

EJNMMI radiopharmacy and chemistry

European journal of nuclear medicine and molecular imaging

Molecular imaging and biology

This page only lists publications with an associated author ORCID identifier.

Publications

Circe D van der Heide, Hanyue Ma, Mark W H Hoorens, Joana D Campeiro, Debra C Stuurman, Corrina M A de Ridder, Yann Seimbille, Simone U Dalm
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Circe D van der Heide, Hanyue Ma, Mark W H Hoorens, Joana D Campeiro, Debra C Stuurman, Corrina M A de Ridder, Yann Seimbille, Simone U Dalm
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Circe D van der Heide, Hanyue Ma, Mark W H Hoorens, Joana D Campeiro, Debra C Stuurman, Corrina M A de Ridder, Yann Seimbille, Simone U Dalm
In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
T S T Damiana, P Paraïso, C de Ridder, D Stuurman, Y Seimbille, Simone U Dalm
Side-by-side comparison of the two widely studied GRPR radiotracers, radiolabeled NeoB and RM2, in a preclinical setting. European journal of nuclear medicine and molecular imaging (2023)
Marjolein Verhoeven, Joost Haeck, Erik de Blois, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Mark Konijnenberg, Simone U Dalm
The Balance Between the Therapeutic Efficacy and Safety of [ 177 Lu]Lu-NeoB in a Preclinical Prostate Cancer Model. Molecular imaging and biology (2023)
Eline A M Ruigrok, Marjolein Verhoeven, Mark W Konijnenberg, Erik de Blois, Corrina M A de Ridder, Debra C Stuurman, Luisa Bertarione, Katia Rolfo, Marion de Jong, Simone U Dalm
Safety of [<sup>177</sup>Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity. European journal of nuclear medicine and molecular imaging 49 (13) (2022)
Circe D van der Heide, Simone U Dalm
Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine. European journal of nuclear medicine and molecular imaging 49 (13) (2022)
Rosalba Mansi, Berthold A Nock, Simone U Dalm, Martijn B Busstra, Thomas A Kirkland, Theodosia Maina
Radiolabeled Bombesin Analogs. Cancers 13 (22) (2021)